World Top 1,000 Companies as of January 2024
World Rank (Jan-05-2024)
18,624
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
20,272
Market Cap (Jul-30-2023)
0.131 Billion USD
World Rank (Dec-25-2022)
21,183
Market Cap (Dec-25-2022)
0.109 Billion USD
World Rank (Jan-07-2022)
19,843
Market Cap (Jan-07-2022)
0.17 Billion USD
World Rank (Jan-05-2024)
18,625
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
20,031
Market Cap (Jul-30-2023)
0.137 Billion USD
World Rank (Dec-25-2022)
20,585
Market Cap (Dec-25-2022)
0.122 Billion USD
World Rank (Jan-07-2022)
23,549
Market Cap (Jan-07-2022)
0.09 Billion USD
World Rank (Jan-05-2024)
18,626
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
18,771
Market Cap (Jul-30-2023)
0.175 Billion USD
World Rank (Dec-25-2022)
18,574
Market Cap (Dec-25-2022)
0.180 Billion USD
World Rank (Jan-07-2022)
19,615
Market Cap (Jan-07-2022)
0.18 Billion USD
World Rank (Jan-05-2024)
18,627
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
18,941
Market Cap (Jul-30-2023)
0.170 Billion USD
World Rank (Dec-25-2022)
25,218
World Rank (Jan-07-2022)
25,218
Market Cap (Jan-07-2022)
0.07 Billion USD
World Rank (Jan-05-2024)
18,628
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
18,125
Market Cap (Jul-30-2023)
0.197 Billion USD
World Rank (Dec-25-2022)
17,744
Market Cap (Dec-25-2022)
0.211 Billion USD
World Rank (Jan-07-2022)
18,075
Market Cap (Jan-07-2022)
0.24 Billion USD
Annual Revenue in USD
38 Million USD
Annual Net Income in USD
32 Million USD
Annual Results for Period Ending
Dec-2020 ending year
World Rank (Jan-05-2024)
18,628
World Rank (Jul-30-2023)
18,628
Market Cap (Jul-30-2023)
0.179 Billion USD
World Rank (Dec-25-2022)
14,184
Market Cap (Dec-25-2022)
0.382 Billion USD
World Rank (Jan-07-2022)
7,756
Market Cap (Jan-07-2022)
1.39 Billion USD
Annual Revenue in USD
52 Million USD
Annual Net Income in USD
-428 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Sorrento Therapeutics is a Biotechnology company assets are complemented by an innovative lymphatic targeting device designed to deliver antibodies into the lymphatic system where immune cells are trained to fight cancer. The company annual revenue is 31 million USD and 382 employees as on 2020. The headquarters is in USA.
World Rank (Jan-05-2024)
18,628
World Rank (Jul-30-2023)
18,628
Market Cap (Jul-30-2023)
0.179 Billion USD
World Rank (Dec-25-2022)
18,621
Market Cap (Dec-25-2022)
0.179 Billion USD
World Rank (Jan-07-2022)
19,985
Market Cap (Jan-07-2022)
0.17 Billion USD
World Rank (Jan-05-2024)
18,629
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
18,644
Market Cap (Jul-30-2023)
0.179 Billion USD
World Rank (Dec-25-2022)
18,706
Market Cap (Dec-25-2022)
0.176 Billion USD
World Rank (Jan-07-2022)
18,999
Market Cap (Jan-07-2022)
0.20 Billion USD
World Rank (Jan-05-2024)
18,630
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
18,042
Market Cap (Jul-30-2023)
0.201 Billion USD
World Rank (Dec-25-2022)
19,147
Market Cap (Dec-25-2022)
0.162 Billion USD
World Rank (Jan-07-2022)
15,843
Market Cap (Jan-07-2022)
0.34 Billion USD
World Rank (Jan-05-2024)
18,631
Market Cap (Jan-05-2024)
0.174 Billion USD
World Rank (Jul-30-2023)
18,191
Market Cap (Jul-30-2023)
0.195 Billion USD
World Rank (Dec-25-2022)
21,742
Market Cap (Dec-25-2022)
0.098 Billion USD
World Rank (Jan-07-2022)
21,720
Market Cap (Jan-07-2022)
0.12 Billion USD